Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
REPH - As of  10/18/18, 03:01:41 AM:   37 Insider Transactions.

Sector: Healthcare    Industry: Biotechnology
Prev Close:$7.73  Avg Vol(3m): 18,832  P/E: 0.00  EPS: -0.06

Email this page to a friend.    Insider Transactions for REPH

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
S 2018-05-24 17:10:08.0 Recro Pharma REPH Broadfin Capital 9.99% view
S 2018-03-21 16:05:01.0 Recro Pharma REPH Stonepine Capital Management 0.5% view
B 2018-03-15 16:19:13.0 Recro Pharma REPH Broadfin Capital 10.0% view
S 2018-03-08 15:50:39.0 Recro Pharma REPH BlackRock Inc 4.99% view
B 2018-02-14 14:36:10.0 Recro Pharma REPH Alyeska Investment Group 5.3% view
S 2018-02-14 09:40:24.0 Recro Pharma REPH LYTTON LAURENCE W 4.6% view
S 2018-02-14 08:42:28.0 Recro Pharma REPH Flynn James E 9.94% view
S 2018-02-13 17:08:01.0 Recro Pharma REPH Stonepine Capital Management 5.5% view
B 2018-02-01 09:25:06.0 Recro Pharma REPH BlackRock Inc 5.3% view
S 2017-12-14 16:08:50.0 Recro Pharma REPH Broadfin Capital 10.0% view
B 2017-12-04 16:13:58.0 Recro Pharma REPH Broadfin Capital 14.15% view
S 2017-11-24 13:22:50.0 Recro Pharma REPH Broadfin Capital 10.0% view
B 2017-05-19 14:30:20.0 Recro Pharma REPH LYTTON LAURENCE W 6.2% view
S 2017-05-15 17:52:06.0 Recro Pharma REPH Stonepine Capital Management 9.99% view
B 2017-02-14 08:25:02.0 Recro Pharma REPH Flynn James E 10.9% view
B 2016-12-19 13:40:59.0 Recro Pharma REPH Stonepine Capital Management 15.2% view
B 2016-12-16 15:47:04.0 Recro Pharma REPH Flynn James E 10.9% view
S 2016-12-14 15:07:32.0 Recro Pharma REPH Broadfin Capital 16.43% view
B 2016-08-17 15:45:48.0 Recro Pharma REPH Broadfin Capital 20.66% view
B 2016-07-21 16:20:48.0 Recro Pharma REPH STONEPINE CAPITAL 5.5% view
B 2016-01-11 10:40:17.0 Recro Pharma REPH SABBY MANAGEMENT 12.0% view
B 2015-07-17 13:02:38.0 Recro Pharma REPH Tourbillon Capital Partners LP 7.0% view
B 2015-07-15 13:05:06.0 Recro Pharma REPH Broadfin Capital 10.6% view
S 2015-02-23 15:39:31.0 Recro Pharma REPH Avet Capital Management 0.4% view
B 2015-02-17 16:22:05.0 Recro Pharma REPH Cormorant Global Healthcare Master Fund 9.1% view
B 2015-02-17 11:27:10.0 Recro Pharma REPH Broadfin Capital 10.6% view
S 2015-02-17 10:29:49.0 Recro Pharma REPH GREAT POINT PARTNERS LLC 0.0% view
S 2015-02-13 07:20:20.0 Recro Pharma REPH Opaleye Management Inc 0.0% view
B 2015-01-12 09:36:01.0 Recro Pharma REPH SABBY MANAGEMENT 9.96% view
B 2014-09-15 15:38:29.0 Recro Pharma REPH Broadfin Capital 10.6% view
B 2014-09-04 13:09:17.0 Recro Pharma REPH Avet Capital Management 5.1% view
B 2014-07-24 07:13:50.0 Recro Pharma REPH Opaleye Management Inc 5.12% view
B 2014-03-21 10:48:07.0 Recro Pharma n/a SCP Vitalife Partners II LP 44.3% view
B 2014-03-18 15:43:37.0 Recro Pharma n/a GREAT POINT PARTNERS LLC 8.12% view
B 2014-03-17 16:14:06.0 Recro Pharma n/a Cormorant Asset Management 7.0% view
B 2014-03-14 09:42:37.0 Recro Pharma n/a SABBY MANAGEMENT 5.99% view
B 2014-03-13 15:27:17.0 Recro Pharma n/a Broadfin Capital 8.1% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.